I disagree completely.
This manipulation has been a reality for months and months, manipulating SP on low volume daily, when no news. All level 2 data shows this. The naked shorting figures just confirms the criminal activities going on at hedge level.
All the "everything is management fault" is not founded in facts.
TLD has NOT been announced by NWBO, why they are still embargoed by journal to say anything of substance and why results have been talked about by 3rd. parties. Some believe otherwise but fact is, that TLD has NOT been announced on NWBO's own website and that results are situated anywhere else.
Not saying anything during data lock, was a genius stroke and I have argued for that over and over again. Anything NWBO would have said during data lock with no way to support with results, would've made them a target - just as now - for manipulation and bitching and whining from fudders, as well as they would've had to divert attention, money and efforts dealing with issues like fraudulent fiduciary lawsuits and disinformation from bloggers like Adam Feuerstein. NOTHING would've been gained.
But while management has been quiet on substantial matters, we STILL know that NWBO have been progressing ON substantial matters.
1) MHRA certified Sawston
2) Biosimilarity test manual vs. Flaskworks automation since last summer. Results: They are almost ready for scaling up to 12.000 patients yearly. NO other immunology company can automate on this level. They are years in front of the competition. Doses are cleaner and therefore probably more effective, than manual counterparts.
3) Signs that work on approval in England has been going on for a while. Bosch in England to talk to scientist. Liau in England before ASCO. Linda Powers in England to talk to british politicians facilitated by british cancer organisation Braintumourresearch.org.
4) Linda Liau has continously the last year informed about UCLA's largest cancer project the SPORE 1 project between Mercks Keytruda and DCVax-L and about the astounding efficacy.
5) Two PR people have now been attached to NWBO, one with experience in world wide promotion.
We can all agree, that it is not fun, it is tiresome, to be waiting. But no where, there are signs, that management are doing nothing to get TLD and a journal out, with signs of approval work going on in England. Rather it looks more and more like an accumulation of news to be announced AT LATEST at ASM, but probably before.
Until then, no one ... with the latest information about £350 mill. being made available in England for PIM funding and thus perhaps a good chunk to NWBO and with no knowledge about how many money warrants have brougth to the NWBO wallet ... have any idea about "next offering" or dilution.
But we CAN see, what is going on right in front of our eyes and that is not management sitting passively on their behinds.
